StockData
Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc. (RPID) stock

RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3050% below fair value
$0.74−0.00 (-0.43%)

Close on Nov 17, 2026Market cap $36.96MP/E –Yield –

Rapid Micro Biosystems operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Rapid Micro Biosystems's operating cash flow for the twelve months ending Jun 30, 2026 was -$40.06M. For fiscal 2025 it was -$31.06M. The highest annual figure on record is -$31.00M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$31.06M–
FY2024Dec 31, 2024-$44.15M–
FY2023Dec 31, 2023-$45.08M–
FY2022Dec 31, 2022-$58.55M–
FY2021Dec 31, 2021-$54.96M–
FY2020Dec 31, 2020-$31.00M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.70M–
Q1 FY2026Mar 31, 2026-$15.06M–
Q4 FY2025Dec 31, 2025-$3.25M–
Q3 FY2025Sep 30, 2025-$9.05M–
Q2 FY2025Jun 30, 2025-$9.70M–
Q1 FY2025Mar 31, 2025-$9.07M–
Q4 FY2024Dec 31, 2024-$9.91M–
Q3 FY2024Sep 30, 2024-$8.60M–
Q2 FY2024Jun 30, 2024-$10.12M–
Q1 FY2024Mar 31, 2024-$15.53M–
Q4 FY2023Dec 31, 2023-$9.50M–
Q3 FY2023Sep 30, 2023-$9.71M–
Q2 FY2023Jun 30, 2023-$9.19M–
Q1 FY2023Mar 31, 2023-$16.69M–
Q4 FY2022Dec 31, 2022-$11.66M–
Q3 FY2022Sep 30, 2022-$15.11M–
Q2 FY2022Jun 30, 2022-$14.99M–
Q1 FY2022Mar 31, 2022-$16.80M–
Q4 FY2021Dec 31, 2021-$12.89M–
Q3 FY2021Sep 30, 2021-$19.31M–
Q2 FY2021Jun 30, 2021-$11.51M–
Q1 FY2021Mar 31, 2021-$11.26M–
Q4 FY2020Dec 31, 2020-$5.17M–
Q3 FY2020Sep 30, 2020-$8.82M–

More Rapid Micro Biosystems figures

See a number that looks wrong?